RESUMEN
OBJECTIVE: To describe a bilateral thoracoscopic sympathectomy procedure, using a biportal approach, for the treatment of severe hyperhidrosis. METHODS: Between May 1996 and September 2000, 103 consecutive patients underwent thoracoscopic sympathectomy procedures to treat bilateral hyperhidrosis (206 procedures). Operative results, complications, and patient satisfaction were determined by reviews of hospital and office charts and by follow-up assessments in the outpatient clinic. Long-term results were determined with clinical examinations, follow-up office visits, and follow-up questionnaires. RESULTS: Ninety-three patients presented with primary palmar hyperhidrosis, eight with primary axillary hyperhidrosis, and two with primary craniofacial hyperhidrosis. Rates of complete resolution in the primary area affected were 100% in palmar and craniofacial cases and 75% in axillary cases. The average length of hospitalization was 1.06 days, and 96 patients (93.2%) were discharged on or before the end of the first postoperative day. Of 59 patients (57.3%) who developed compensatory hyperhidrosis, only 11 patients (10.7%) reported that it was bothersome and none considered it disabling. All postoperative complications were transient; five patients experienced unilateral Horner's syndrome, three patients experienced intercostal neuralgia, and two patients required a chest tube after surgery because of a pneumothorax. CONCLUSION: Thoracoscopic sympathectomy using a biportal approach effectively treats hyperhidrosis and is associated with short hospital stays, high patient satisfaction rates, and low rates of compensatory hyperhidrosis or other complications.
Asunto(s)
Hiperhidrosis/cirugía , Microcirugia/instrumentación , Complicaciones Posoperatorias/etiología , Simpatectomía/instrumentación , Toracoscopios , Adolescente , Adulto , Femenino , Estudios de Seguimiento , Lateralidad Funcional/fisiología , Ganglios Simpáticos/patología , Ganglios Simpáticos/cirugía , Humanos , Masculino , Persona de Mediana Edad , Examen Neurológico , Estudios Retrospectivos , Instrumentos Quirúrgicos , Resultado del TratamientoRESUMEN
OBJECTIVE: Anterior lumbar interbody fusion (ALIF) has gained popularity for the treatment of degenerative disease of the lumbar spine. In this report, we present our experience with the ALIF procedure for treatment of failed back surgery syndrome (FBSS) in a noncontrolled prospective cohort. METHODS: In a 2-year period, we treated patients diagnosed with FBSS with ALIF. Clinical and radiological outcomes were recorded in a prospective, nonrandomized, longitudinal manner. Neurological, pain, and functional outcomes were measured preoperatively and 12 months after surgery. Operative data, perioperative complications, and radiological and clinical outcomes were recorded. RESULTS: Thirty-three patients with a preoperative diagnosis of FBSS, with degenerative disc disease (n = 17), postsurgical spondylolisthesis (n = 13), or pseudarthrosis (n = 3), underwent ALIF. Back pain, leg pain, and functional status improved significantly, by 76% (P < 0.01), 80% (P < 0.01), and 67% (P < 0.01), respectively. CONCLUSION: On the basis of our results, we found ALIF to be a safe and effective procedure for the treatment of FBSS for selected patients.
Asunto(s)
Dolor de la Región Lumbar/cirugía , Vértebras Lumbares/cirugía , Complicaciones Posoperatorias/cirugía , Seudoartrosis/cirugía , Radiculopatía/cirugía , Fusión Vertebral/métodos , Osteofitosis Vertebral/cirugía , Espondilolistesis/cirugía , Actividades Cotidianas/clasificación , Adulto , Anciano , Femenino , Humanos , Dolor de la Región Lumbar/diagnóstico , Masculino , Persona de Mediana Edad , Examen Neurológico , Evaluación de Resultado en la Atención de Salud , Dimensión del Dolor , Complicaciones Posoperatorias/diagnóstico , Estudios Prospectivos , Seudoartrosis/diagnóstico , Radiculopatía/diagnóstico , Recurrencia , Reoperación , Osteofitosis Vertebral/diagnóstico , Espondilolistesis/diagnóstico , Síndrome , Insuficiencia del TratamientoRESUMEN
BACKGROUND: Hyperhidrosis (HH) profoundly affects a patient's well-being. OBJECTIVE: We report indications and outcomes of 322 patients treated for HH via thoracoscopic sympathectomy or sympathotomy at the Barrow Neurological Institute. METHODS: A prospectively maintained database of all patients who underwent sympathectomy or sympathotomy between 1996 and 2008 was examined. Additional follow-up was obtained in clinic, by phone, or by written questionnaire. RESULTS: A total of 322 patients (218 female patients) had thoracoscopic treatment (mean age 27.6 years; range, 10-60 years). Mean follow-up was 8 months. Presentations included HH of the palms (43 patients, 13.4%), axillae (13 patients, 4.0%), craniofacial region (4 patients, 1.2%), or some combination (262 patients, 81.4%). Sympathectomy and sympathotomy were equally effective in relieving HH. Palmar HH resolved in 99.7% of patients. Axillary or craniofacial HH resolved or improved in 89.1% and 100% of cases, respectively. Hospital stay averaged 0.5 days. Ablating the sympathetic chain at T5 increased the incidence of severe compensatory sweating (P = .0078). Sympathectomy was associated with a significantly higher incidence of Horner's syndrome compared with sympathotomy (5% vs 0.9%, P = .0319). Patients reported satisfaction and willingness to undergo the procedure again in 98.1% of cases. CONCLUSION: Thoracoscopic sympathectomy is effective and safe treatment for severe palmar, axillary, and craniofacial HH. Ablating the T5 ganglion tends to increase the severity of compensatory sweating. Sympathectomy led to a higher incidence of ipsilateral Horner's syndrome compared with sympathotomy.
Asunto(s)
Ganglios Simpáticos/cirugía , Ganglionectomía/métodos , Síndrome de Horner/epidemiología , Hiperhidrosis/cirugía , Simpatectomía/métodos , Toracoscopía/métodos , Adolescente , Adulto , Niño , Femenino , Ganglios Simpáticos/fisiopatología , Síndrome de Horner/fisiopatología , Síndrome de Horner/prevención & control , Humanos , Hiperhidrosis/patología , Hiperhidrosis/fisiopatología , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Adulto JovenRESUMEN
Since the Food and Drug Administration approved the Babgy-Kuslich BAK cage for anterior lumbar interbody fusion (ALIF), various threaded interbody fusion devices have been introduced. Bone dowels offer several theoretical advantages over cages with regard to stress shielding; the purpose of this study was to assess the efficacy of bone dowels in interbody fusion. All patients undergoing ALIF performed by the senior author between 1998 and 2001 were retrospectively reviewed. Patients' preoperative and postoperative neurologic status, functional status, and both back and radicular pain were assessed according to a previously published outcome measure. Between 1998 and 2000, 23 patients underwent ALIF with cortical femoral allograft bone dowels. One patient underwent simultaneous bone dowel and titanium cage placements and was therefore excluded from further analysis. The 22 remaining patients underwent a total of 33 fused segments; of these, 21 patients were available for follow-up. Mean clinical follow-up was 30.6 months. Mean imaging follow-up was 21 months. There were 5 instances of radiographic nonunion (3 symptomatic and 2 asymptomatic). The incidence of technical failures and complications related to the bone dowels was 17%. Bone dowels failed and caused symptoms only in patients with a stand-alone ALIF. There were no clinical failures in patients treated with supplemental anterior or posterior spinal fixation. These data demonstrate that marginal fusion rates and functional success rates can be achieved using stand-alone bone dowels for ALIF. The clinical success and fusion rates are significantly higher if ALIF dowels are shielded from stress with rigid spinal instrumentation.